Elek G, Lapis K, Földes I
J Toxicol Environ Health. 1979 Mar-May;5(2-3):529-36. doi: 10.1080/15287397909529764.
Immunization of CBAT6T6 mice with MC-29 hepatoma antigen did not change the take of Rous sarcoma virus, Schmidt-Ruppin strain [RSV(SR)] mouse tumors after sc transplantation. Immunization with MC-29 hepatoma antigen only slightly increased the average survival time of the mice and significantly decreased tumor growth only at the minimal lethal dose level. Immunization of mice with MC-29 hepatoma antigen and immunization with chicken Rous sarcoma gave similar results; both elicited much less transplantation resistance than immunization with irradiated RSV(SR) mouse tumor cells. The data indicate that there are common tumor-specific transplantation antigens of MC-29 hepatoma and Rouse sarcoma, but further in vitro experiments are needed to prove this.
用MC - 29肝癌抗原免疫CBAT6T6小鼠,对施密特 - 鲁平株劳氏肉瘤病毒[RSV(SR)]小鼠肿瘤皮下移植后的接种情况没有影响。用MC - 29肝癌抗原免疫仅略微延长了小鼠的平均存活时间,且仅在最小致死剂量水平显著降低了肿瘤生长。用MC - 29肝癌抗原免疫小鼠和用鸡劳氏肉瘤免疫得到了相似的结果;两者引发的移植抗性都比用经辐射的RSV(SR)小鼠肿瘤细胞免疫引发的移植抗性小得多。数据表明,MC - 29肝癌和劳氏肉瘤存在共同的肿瘤特异性移植抗原,但需要进一步的体外实验来证实这一点。